Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × IFL protocol × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

INDUSTRY 61 OTHER 47 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Oxaliplatin 29 Capecitabine 26 Irinotecan 19 Fluorouracil 19 tislelizumab 18 apatinib 14 Paclitaxel 13 Cisplatin 13 S 1 (combination) 12 Radiotherapy 12 Bevacizumab 11 Leucovorin 10 Laparoscopy 9 Cetuximab 9 sintilimab 8 Endoscopic Mucosal Resection 8 Drug Therapy 8 Gemcitabine 7 Docetaxel 7 XELOX 6 Radiation 6 Propranolol 6 Nivolumab 6 Neoadjuvant Therapy 6 Immune Checkpoint Inhibitors 6 Folfox protocol 6 camrelizumab 5 Surgical Procedures, Operative 5 Levoleucovorin 5 HMPL-013 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03940131 2022-04-06

REPAN

King Abdullah Medical City

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡